市場調查報告書
商品編碼
1415432
動態心電圖機市場:按產品類型、導極類型和最終用戶分類 - 全球預測 2024-2030 年Holter ECG Market by Product (Software, Wired Holter ECG Monitors, Wireless Holter ECG Monitors), Lead Type (12-Lead, 3-Lead, 6-Lead), End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
動態心電圖市場規模預計2023年為4.4699億美元,2024年將達到4.7265億美元,2030年將達到6.7603億美元,複合年成長率為6.08%。
動態心電圖儀的全球市場
主要市場統計 | |
---|---|
基準年[2023] | 44699萬美元 |
預測年份 [2024] | 47265萬美元 |
預測年份 [2030] | 67603萬美元 |
複合年成長率(%) | 6.08% |
動態心電圖機是醫生用來診斷和監測心律不整患者的醫療設備。這些設備連續記錄 24 至 48 小時的心電圖 (ECG) 訊號,以檢測需要進一步調查或治療的異常心率或心律不整。隨著心血管疾病(CVD)的流行、人口老化和心律不整風險的增加、遠端心臟監測技術的進步以及早期診斷和預防性醫療措施意識的提高,動態心電圖(Holter)用於正確診斷和治療變得越來越重要。對高效率醫療設備(包括心電圖機)的需求不斷成長。然而,動態心電圖設備的高成本對小型醫療機構造成了財務障礙。用於遠端患者監護的遠端醫療監護儀製造商創造了新的機會,以擴大其產品在全球的覆蓋範圍。
區域洞察
動態心電圖機市場正在美洲發展,由於人口老化和心臟病發病率增加,人們越來越關注心臟健康。我們致力於透過研究和技術投資來改善心臟護理,從而提高美洲的診斷能力。在歐盟 (EU),醫療保健提供者正在採用動態心電圖等先進技術,透過早期檢測心臟疾病來改善患者的治療結果。在 EMEA(歐洲、中東和非洲)地區,隨著各國政府專注於發展醫療保健基礎設施和促進醫療旅遊,對先進醫療保健服務的需求正在快速成長。非洲人民越來越意識到預防心臟病的措施,增加了對包括心臟心電圖在內的診斷解決方案的需求。在亞太地區,醫療設備的研究和開發,加上強調心臟病早期診斷和早期療育重要性的政府計劃和計劃,導致該地區的醫療機構擴大採用動態心電圖監測儀。此外,技術進步和最尖端科技的整合預計將提高精度和準確度,加速全球最終用戶對動態心電圖的使用。
FPNV定位矩陣
FPNV定位矩陣對於評估動態心電圖機市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對動態心電圖市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-動態心電圖機市場的市場規模與預測是多少?
2-動態心電圖市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3-動態心電圖機市場的技術趨勢和法律規範是什麼?
4-動態心電圖機市場主要廠商的市場佔有率是多少?
5-進入動態心電圖市場的合適型態和策略手段是什麼?
[196 Pages Report] The Holter ECG Market size was estimated at USD 446.99 million in 2023 and expected to reach USD 472.65 million in 2024, at a CAGR 6.08% to reach USD 676.03 million by 2030.
Global Holter ECG Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 446.99 million |
Estimated Year [2024] | USD 472.65 million |
Forecast Year [2030] | USD 676.03 million |
CAGR (%) | 6.08% |
Holter ECG is a medical device that enables physicians to diagnose and monitor patients with heart rhythm disorders. These devices continuously record electrocardiogram (ECG) signals for 24 to 48 hours to detect abnormal heartbeats or arrhythmias requiring further investigation and treatment. Prevalence of cardiovascular diseases (CVDs), increasing aging population with increased risk of arrhythmias, technological advancements in remote cardiac monitoring, and growing awareness regarding early diagnosis and preventive healthcare measures are raising the need for efficient medical devices, including holter ECG, for appropriate diagnosis and treatment. However, the high cost of Holter ECG devices can be a financial barrier for small-scale healthcare facilities. The surge in the adoption of telemedicine services in remote patient monitoring has also created new opportunities for Holter ECG manufacturers to expand their product reach worldwide.
Regional Insights
The Holter ECG market is evolving in the Americas owing to the growing focus on cardiac health due to an aging population and increasing incidences of heart disease. Emphasis on improving cardiac care through investments in research and technology enhances diagnostic capabilities in the Americas. In the European Union, healthcare providers are adopting advanced technologies such as Holter ECG to improve patient outcomes by early detection of heart diseases. The EMEA region has experienced rapid growth in demand for advanced healthcare services with a focus on governments on healthcare infrastructure development and promoting medical tourism. There has been an increasing focus on creating awareness about preventive measures for cardiac conditions among the African population, raising the need for diagnostic solutions, including heart ECG. The APAC region is focusing on medical device research and development coupled with government schemes and programs emphasizing the importance of early diagnosis and intervention for cardiac conditions, which are expanding the deployment of Holter ECG in the healthcare facilities in the region. Besides, the technological advancements and integration of cutting-edge technologies are anticipated to enhance accuracy and precision, thereby accelerating the use of Holter ECG by end-users across the globe.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Holter ECG Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Holter ECG Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Holter ECG Market, highlighting leading vendors and their innovative profiles. These include AlivCor Inc., Bardy Diagnostics, Inc., BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED, Cardiac Insight, Inc., custo med GmbH, EB Neuro S.p.A., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom Holdings, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., LifeSignals Group Inc., Medtronic plc, Nasiff Associates, Inc., Nihon Kohden Corporation, Nissha Co. Ltd., OSI Systems, Inc., SCHILLER AG, Viatom Technology Co. Ltd., and VitalConnect.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Holter ECG Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Holter ECG Market?
3. What are the technology trends and regulatory frameworks in the Holter ECG Market?
4. What is the market share of the leading vendors in the Holter ECG Market?
5. Which modes and strategic moves are suitable for entering the Holter ECG Market?